Bioceres Crop Solutions (NASDAQ:BIOX) Releases Earnings Results, Misses Estimates By $0.10 EPS

Bioceres Crop Solutions (NASDAQ:BIOX) issued its quarterly earnings results on Monday. The company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.10), MarketWatch Earnings reports. The business had revenue of $104.70 million for the quarter, compared to analyst estimates of $96.59 million. Bioceres Crop Solutions had a return on equity of 5.37% and a net margin of 3.56%. During the same quarter last year, the firm posted ($0.12) EPS.

Bioceres Crop Solutions Trading Down 6.0 %

BIOX opened at $11.00 on Wednesday. Bioceres Crop Solutions has a 1-year low of $9.76 and a 1-year high of $15.13. The company has a current ratio of 1.39, a quick ratio of 0.89 and a debt-to-equity ratio of 0.43. The company has a market cap of $696.62 million, a P/E ratio of 55.00 and a beta of 0.42. The company has a fifty day moving average price of $12.14 and a two-hundred day moving average price of $11.82.

Institutional Investors Weigh In On Bioceres Crop Solutions

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC increased its stake in Bioceres Crop Solutions by 14.6% in the second quarter. Geode Capital Management LLC now owns 34,171 shares of the company’s stock valued at $457,000 after purchasing an additional 4,356 shares in the last quarter. UBS Group AG increased its stake in Bioceres Crop Solutions by 4.7% in the first quarter. UBS Group AG now owns 37,468 shares of the company’s stock valued at $435,000 after purchasing an additional 1,676 shares in the last quarter. Stifel Financial Corp bought a new stake in Bioceres Crop Solutions in the first quarter valued at $361,000. Millennium Management LLC bought a new stake in Bioceres Crop Solutions in the fourth quarter valued at $323,000. Finally, Sei Investments Co. bought a new stake in shares of Bioceres Crop Solutions during the second quarter worth about $221,000. 13.35% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on BIOX shares. Roth Mkm reiterated a “buy” rating and set a $31.00 price target on shares of Bioceres Crop Solutions in a report on Tuesday. Lake Street Capital dropped their target price on shares of Bioceres Crop Solutions from $30.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday. Four analysts have rated the stock with a buy rating, According to MarketBeat, Bioceres Crop Solutions presently has an average rating of “Buy” and a consensus target price of $23.67.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates in three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops.